日本医真菌学会総会プログラム・抄録集
Print ISSN : 0916-4804
The 51st Annual Meeting of the Japanese Society for Medical Mycology
セッションID: SYI-3
会議情報

International cross-talk on moving dimension of medical mycology
Biosynthetic pathway of GPI-anchored cell wall mannoproteins in yeast as a potential target for anti-fungal and anti-cancer drugs
*Yoshifumi Jigami
著者情報
会議録・要旨集 フリー

詳細
抄録
GPI-anchored mannoproteins are one of the major cell wall components of eukaryotic microorganisms, including yeast and fungi. Some of GPI-anchored proteins are localized at the plasma membrane, but the others are further processed at the plasma membrane and are covalently linked to beta-1,6-glucan of the cell wall through the GPI portion. The genes and enzymes responsible for their biosynthesis and its cell wall assembly are potential targets of anti-fungal reagents. We identified GWT1 as a target of new anti-fungal drug candidates and elucidated its function to be involved in the acylation of inositol ring. We also found a new function of GPI7, which is involved in transfer of ethanolamine phosphate to Man2 of GPI. Our results indicate that the localization of GPI-anchored endoglucanase Egt2p is displaced from the septal region to the cell cortex at the restrictive temperature in gpi7Δ cells, suggesting that GPI7 is involved in the separation of mother and daughter cells and its defective phenotype is a good marker to select a new inhibitor towards Gpi7 function.
We have recently reported that PER1 is involved in lipid remodeling of GPI-anchored proteins, indicating that Per1p has a GPI-phospholipase A2 activity to eliminate unsaturated fatty acyl chain at the sn-2 position of PI moiety. We further found that human PERLD1, which is now known as an oncogene, is a functional homologue of yeast PER1, indicating that this is a potential target for new anti-cancer drugs.
著者関連情報
© 2007 The Japanese Society for Medical Mycology
前の記事 次の記事
feedback
Top